Skip to main content

Table 4 Allele and genotype frequencies of CETP Taq I B polymorphism in T2DM patients and controls after stratifying in male and female

From: Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study

 

Male*

Female*

 

Patient n (%)

Control n (%)

P-value

OR (95% CI)

Patient n (%)

Control n (%)

P-value

OR (95% CI)

B1B1

22 (27.8)

34 (29.3)

0.825

0.93 (0.49–1.76)

18 (31.6)

38 (25.7)

0.395

1.34 (0.68–2.61)

B1B2

44 (55.7)

60 (51.7)

0.585

1.17 (0.66–2.08)

29 (50.9)

74 (50.0)

0.910

1.04 (0.56–1.91)

B2B2

13 (16.5)

22 (19.0)

0.654

0.84 (0.40–1.79)

10 (17.5)

36 (24.3)

0.297

0.66 (0.30–1.44)

B1

88 (55.70)

128 (55.17)

0.920

1.02 (0.68–1.53)

65 (57.02)

150 (50.68)

0.249

1.29 (0.84–2.00)

B2

70 (44.30)

104 (44.83)

0.920

0.98 (0.65–1.47)

49 (42.98)

146 (49.32)

0.249

0.77 (0.50–1.20)

  1. * Total male patients 79, controls 116 and total female patients 57, controls 148
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us